OS Therapies Incorporated (OSTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 124.94K | 124.94K | 0 | 112.51K | 0 | 1.39K | 0 | 695 | 695 | 0 | 3.31K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -124.94K | -124.94K | 0 | -112.51K | 0 | -1.39K | 0 | -695 | -695 | 0 | -3.31K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -8888.35% | - | -16089.06% | 100% | - | 100% | - | - | - | - | 100% |
| Operating Expenses | 10.04M | 11.86M | 6.88M | 4.73M | 5M | 2.97M | 2.44M | 779.8K | 630.23K | 1.16M | 618.89K | 1.05K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.82M | 12.34B | 3.12M | 2.34M | 3.69M | 2.1M | 1.23M | 383.23K | 268.42K | 132.88K | 167.7K | 294 |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.23M | 16.35B | 3.76M | 2.5M | 1.31M | 869.08K | 1.21M | 396.57K | 361.81K | 1.02M | 451.19K | 754 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 0 | -112.51K | 0 | 0 | 0 | 0 | 0 | 5.15K | 0 | 0 |
| Operating Income | -10.17M | -11.99M | -6.88M | -4.84M | -5M | -2.97M | -2.44M | -779.8K | -630.23K | -1.16M | -622.21K | -1.05K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -103.38% | -304.12% | -182.25% | -520.51% | -693.28% | -156.38% | -291.73% | - | -60034.86% | -66379.89% | - | -17.84% |
| EBITDA | -10.04M | -11.86M | -6.75M | -4.73M | -5M | -2.97M | -2.44M | -779.11K | -629.54K | -1.16M | -618.89K | -1.05K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -100.91% | -300.1% | -177.13% | -506.62% | -694.04% | -156.26% | -293.83% | - | -59974.28% | -66387.57% | - | -17.85% |
| D&A (Non-Cash Add-back) | 124.94K | 124.94K | 124.94K | 112.51K | 695 | 1.39K | 0 | 695 | 695 | 0 | 3.31K | 0 |
| EBIT | -10.17M | -13.46M | -6.88M | -4.54M | -3.88M | -2.98M | -2.44M | -779.8K | -630.23K | -1.16M | -622.21K | -1.05K |
| Net Interest Income | -75.3K | 54 | 65 | 64 | 66 | -7.56K | -437.84K | -777.68K | -828.76K | -307.53K | -1.35M | -799 |
| Interest Income | 45 | 54 | 65 | 64 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 75.34K | 0 | 0 | 0 | 0 | 7.56K | 437.84K | 777.68K | 828.76K | 307.53K | 1.35M | 799 |
| Other Income/Expense | -228.89K | -1.47M | 65 | 302.11K | 1.12M | -24.81K | -437.84K | -777.68K | -828.76K | -307.53K | -1.35M | -799 |
| Pretax Income | -10.4M | -13.46M | -6.88M | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M | -1.97M | -1.85K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.4M | -13.46M | -6.88M | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M | -1.97M | -1.85K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -168.18% | -350.01% | -139.27% | -191.28% | -165.72% | -104.24% | -45.58% | - | -78893.85% | -57286.49% | - | -35.56% |
| Net Income (Continuing) | -10.4M | -13.46M | -6.88M | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M | -1.97M | -1.85K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.27 | -0.41 | -0.21 | -0.18 | -0.18 | -0.04 | -0.18 | -0.08 | -0.07 | -0.07 | -0.10 | -0.00 |
| EPS Growth % | -50% | -922.44% | -16.67% | -138.1% | -142.26% | 46.25% | -80% | - | - | - | - | - |
| EPS (Basic) | -0.27 | -0.41 | -0.21 | -0.18 | -0.18 | -0.04 | -0.18 | -0.08 | -0.07 | -0.07 | -0.10 | -0.00 |
| Diluted Shares Outstanding | 38.67M | 29.25M | 31.96M | 25.11M | 21.25M | 123.77M | 15.9M | 20.6M | 20.05M | 20.05M | 23.1M | 10.21M |
| Basic Shares Outstanding | 38.67M | 29.25M | 31.96M | 25.11M | 21.25M | 123.77M | 15.9M | 20.6M | 20.05M | 20.05M | 20.05M | 10.04M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |